ストックスクリーナーアプリを入手
29.70
6.19%
1.73
アフターアワーズ：
29.75
0.05
+0.17%
前日終値:
$27.97
開ける：
$27.97
24時間の取引高:
819.39K
Relative Volume:
1.21
時価総額：
$1.08B
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+11.44%
1か月 パフォーマンス:
+68.46%
6か月 パフォーマンス:
+196.11%
1年 パフォーマンス:
+45.02%
1日の値動き範囲:
$27.25
$30.72
1週間の範囲:
$24.60
$30.72
52週間の値動き範囲:
$7.13
$42.27
Rapport Therapeutics Inc Stock (RAPP) Company Profile
RAPP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RAPP
Rapport Therapeutics Inc
|
29.70 | 1.29B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Rapport Therapeutics Inc Stock (RAPP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-16 | 開始されました | Truist | Buy |
| 2025-08-06 | 開始されました | H.C. Wainwright | Buy |
| 2025-04-08 | 開始されました | Citizens JMP | Mkt Outperform |
| 2024-07-02 | 開始されました | Jefferies | Buy |
| 2024-07-02 | 開始されました | Stifel | Buy |
| 2024-07-02 | 開始されました | TD Cowen | Buy |
すべてを表示
Rapport Therapeutics Inc (RAPP) 最新ニュース
Applying Elliott Wave Theory to Rapport Therapeutics Inc.Inflation Watch & Breakout Confirmation Alerts - newser.com
JMP Sees Big Gains in Rapport Therapeutics, Inc. (RAPP) After Focal Epilepsy Study Success - MSN
Using data filters to optimize entry into Rapport Therapeutics Inc.2025 Winners & Losers & Capital Efficiency Focused Ideas - newser.com
Is Rapport Therapeutics Inc. stock recession proofJuly 2025 Sector Moves & Fast Exit Strategy with Risk Control - newser.com
How Harsha Engineers International Limited Performs During Inflation Historical OverviewVolume Profile Analysis & Free Short-Term Trading Strategies - earlytimes.in
What drives Bitdeer Technologies Group stock priceSmall Cap Stock Opportunities & High Yield Investment Portfolio - Early Times
Why Rapport Therapeutics Inc. stock could be next big winnerMarket Growth Summary & Safe Capital Investment Plans - newser.com
Rapport Therapeutics Inc. stock momentum explainedJuly 2025 Selloffs & Verified Momentum Stock Ideas - newser.com
Citizens JMP Maintains Rapport Therapeutics(RAPP.US) With Buy Rating, Raises Target Price to $77 - 富途牛牛
Insider Selling: Rapport Therapeutics (NASDAQ:RAPP) CEO Sells 40,835 Shares of Stock - MarketBeat
Full technical analysis of Rapport Therapeutics Inc. stockQuarterly Trade Review & Real-Time Market Sentiment Reports - newser.com
Aug Levels: Is Rapport Therapeutics Inc a stock for growth or value investorsPortfolio Update Summary & Real-Time Volume Analysis Alerts - خودرو بانک
Truist Financial Initiates Coverage on Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Insider Sell: Can Coterra Energy Inc expand into new marketsWeekly Volume Report & Real-Time Buy Zone Alerts - khodrobank.com
Nasdaq Moves: Is Rapport Therapeutics Inc undervalued by DCF analysisQuarterly Portfolio Summary & Verified Stock Trade Ideas - khodrobank.com
Is Rapport Therapeutics Inc. stock a value trapMarket Growth Report & Verified Swing Trading Watchlists - خودرو بانک
Market Wrap: Why is Rapport Therapeutics Inc stock going up2025 Winners & Losers & Verified Momentum Stock Alerts - khodrobank.com
Brokerages Set Rapport Therapeutics, Inc. (NASDAQ:RAPP) PT at $35.33 - Defense World
Wall Street Zen Upgrades Rapport Therapeutics (NASDAQ:RAPP) to "Hold" - MarketBeat
Long term hold vs stop loss in Rapport Therapeutics Inc.Market Performance Report & Verified Short-Term Plans - newser.com
Rapport Therapeutics (NASDAQ:RAPP) Trading Up 6.6%Here's What Happened - MarketBeat
Insider Stock Buying Reaches US$1.77m On Rapport Therapeutics - 富途牛牛
Rapport Therapeutics, Inc. (NASDAQ:RAPP) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Rapport Therapeutics Announces Public Offering Agreement - MSN
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up After Insider Buying Activity - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Coverage Initiated by Analysts at Truist Financial - Defense World
Why Rapport Therapeutics (RAPP) Is Up 48.9% After Positive Phase 2a Results for RAP-219 in Seizures - Sahm
Truist Securities Initiates Coverage of Rapport Therapeutics (RAPP) with Buy Recommendation - Nasdaq
EPS Watch: What’s the fair value of Rapport Therapeutics Inc. stock2025 Bull vs Bear & Expert Curated Trade Setups - خودرو بانک
Rapport assigned a new Buy at Truist on lead program - Seeking Alpha
Portfolio Shifts: What is Rapport Therapeutics Incs 5 year growth outlook2025 Trading Volume Trends & Weekly Stock Performance Updates - خودرو بانک
Truist Initiates Rapport Therapeutics at Buy With $44 Price Target - MarketScreener
Truist Financial Initiates Rapport Therapeutics(RAPP.US) With Buy Rating, Announces Target Price $44 - 富途牛牛
How to escape a deep drawdown in Rapport Therapeutics Inc.Weekly Trend Recap & Verified Stock Trade Ideas - newser.com
Levels Update: Will Rapport Therapeutics Inc stock go up in YEAR2025 Technical Patterns & Community Supported Trade Ideas - خودرو بانک
Rapport Therapeutics (NASDAQ:RAPP) COO Cheryl Gault Sells 5,000 Shares - MarketBeat
Buyback Watch: Is Rapport Therapeutics Inc a stock for growth or value investorsJuly 2025 Sector Moves & Long-Term Safe Investment Ideas - خودرو بانک
Aug Sentiment: Why is Rapport Therapeutics Inc stock going upMarket Volume Report & Real-Time Volume Triggers - خودرو بانک
MACD Signal: Will Rapport Therapeutics Inc benefit from AI trendsPortfolio Return Report & Weekly Sector Rotation Insights - خودرو بانک
Shorts Report: Is Brown & Brown Inc. stock forming a triangle patternQuarterly Risk Review & Low Risk Entry Point Guides - خودرو بانک
Gains Report: What is Rapport Therapeutics Inc. s 5 year growth outlook2025 Buyback Activity & Fast Momentum Entry Tips - khodrobank.com
Market Trends: What is Rapport Therapeutics Inc. s 5 year growth outlookJuly 2025 Institutional & Stepwise Trade Execution Plans - khodrobank.com
Exit Recap: Does Rapport Therapeutics Inc. meet Warren Buffett’s criteriaJuly 2025 Market Mood & Reliable Intraday Trade Plans - خودرو بانک
Growth Report: Whats the outlook for Rapport Therapeutics Incs sectorJuly 2025 Volume & Fast Entry High Yield Tips - خودرو بانک
Insider Sell: David Bredt Sells 8,500 Shares of Rapport Therapeu - GuruFocus
A Fresh Look at Rapport Therapeutics (RAPP) Valuation After Positive Phase 2a RAP-219 Data Announcement - Sahm
Rapport Therapeutics (NASDAQ:RAPP) Sees Unusually-High Trading Volume Following Analyst Upgrade - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Sets New 12-Month High Following Analyst Upgrade - MarketBeat
Analysts Are Bullish on Top NA Stocks: Rubrik, Inc. Class A (RBRK), Rapport Therapeutics, Inc. (RAPP) - The Globe and Mail
Investors Buy High Volume of Rapport Therapeutics Put Options (NASDAQ:RAPP) - MarketBeat
RAPP Stock Soars 62% in a Week on Meeting Phase II Epilepsy Study Goal - Zacks Investment Research
Rapport Therapeutics Inc (RAPP) 財務データ
Rapport Therapeutics Inc (RAPP) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):